Indo Rama Synth. Q2 FY27 Earnings Call — Analysis (NSE: INDORAMA)
Indo Rama Synthetics reported strong Q2FY27 profit growth with PAT surging 201.8% YoY to ₹74.1 Cr and announced a ₹200 Cr specialty polyester capex with sub-2-year payback.
Result quality: strong — Margin expansion. Management sentiment: optimistic.
The take
Q2FY27 Total Income ₹1,344 Cr ( +10% YoY ) . New guidance — FY28 annual sales volume 4 lakh tonnes FY27, 4.75 lakh plus tonnes FY28 . New story: Specialty Product Mix Shift .
Results
Revenue ₹1,344 Cr +10% YoY; EBITDA ₹117.7 Cr (+46.4% YoY) with margin at 8.8% (+220bps), and PAT at ₹74.1 Cr (+201.8% YoY).
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Total Income | ₹1,344 Cr | +10% | yoy · Q2FY27 |
| EBITDA | ₹117.7 Cr | +46.4% | yoy · Q2FY27 |
| EBITDA Margin | 8.8% | +220bps | yoy · Q2FY27 |
| Finance Cost | ₹29 Cr | -13.7% | yoy · Q2FY27 |
| Profit After Tax | ₹74.1 Cr | +201.8% | yoy · Q2FY27 |
| Total Income | ₹2,284 Cr | -9.7% | yoy · H1FY27 |
| EBITDA | ₹225.7 Cr | +24.9% | yoy · H1FY27 |
| EBITDA Margin | 9.9% | +280bps | yoy · H1FY27 |
| Profit After Tax | ₹137.8 Cr | +78.3% | yoy · H1FY27 |
| Operating Cash Flow | ₹328.5 Cr | +257.1% | yoy · H1FY27 |
| Net Debt | ₹852 Cr | -23.5% | sequential · Q2FY27 · vs Mar-26 (₹1,113 Cr) |
Guidance
Management expects full-year FY27 EBITDA to exceed ₹400 Cr, and targets CY27 commissioning of ₹200 Cr specialty capex generating ~15% top line and 20% EBITDA growth.
What management committed to
- Management expects to achieve [commercial operations of the ₹200 Cr specialty filament and fiber project at Butibori] within Calendar Year 2027. — Q3FY28
- [The ₹200 Cr specialty capex] is expected to generate around 15% growth in top line and a 20% growth in EBITDA with a payback of less than 2 years. — 15% revenue growth, 20% EBITDA growth, <2 yr payback, FY29
- Management expects full-year FY27 EBITDA to exceed [₹400 Cr]. — INR400 plus crores, FY27
- Management expects sales volume to reach [around 4 lakh tonnes in FY27 and return to 4.75 lakh tonnes plus in FY28]. — 4 lakh tonnes FY27, 4.75 lakh plus tonnes FY28, FY28
- Management confirmed [Indo Rama Synthetics] has no plans to expand downstream into weaving or fabrics. — at the moment
Key themes
Specialty capex, deleveraging, and PTA supply tailwinds
How the narrative shifted
- Specialty Product Mix Shift: Investing ₹200 Cr into specialty filament (cationic, dope-dyed) and specialty fibers to expand basket and command 15%+ margins.
- Domestic PTA Capacity Additions: 5.5 million tonnes of domestic PTA capacity entering the market from IOCL and GAIL will replace imports and yield 2-3% margin savings.
- Chinese Competition Abatement: Depreciating INR vs CNY and China's strategic shift out of low-end polyester has diminished competitive import pressure.
- Balance Sheet Deleveraging: Operating cash flows of ₹328.5 Cr in H1 helped cut net debt by 23.5% to ₹852 Cr, creating capacity to fund growth capex prudently.
Operational commentary
- Board approved fresh ₹200 Cr capex for specialty filament and fiber expansion at Butibori complex across the company and subsidiary Indorama Ventures Yarns Pvt Ltd.
- Specialty expansion includes adding extruders on filament machines (115-120 TPD conversion to cationic/dope-dyed specialty, plus 70 TPD new specialty filament) and restarting a closed fiber line with extruders including hollow fiber.
- Operating rate on PSF and POY/filament stands near 100%, while PET chip plant is currently running at ~60% capacity with plans to ramp up as cost dynamics shift.
- Domestic raw material dynamics improving with upcoming 5.5 million tonnes domestic PTA capacity additions by IOCL (Paradip), GAIL (Mangalore), and Reliance, expected to eliminate import logistics penalties and provide 1.5-2% cost savings.
- Macro trade tailwinds from India-UK trade agreement (effective July 2026) and upcoming India-EU and US bilateral agreements, alongside removal of LDC duty advantages for competitors like Bangladesh.
Analyst Q&A
Q. Expected EBITDA per kg or cost savings from upcoming domestic PTA plants by IOCL and GAIL.
Estimated 2-3% margin gain from shifting away from PTA imports, along with 1.5-2% logistics savings due to proximity to eastern/southern plants compared to Gujarat-based competitors.
Q. Details on specialty capex product basket and line capacities.
Adding extruders for cationic and dope-dyed yarns (115-120 TPD converted semi-dull capacity plus 70 TPD new specialty filament), and restarting a dormant fiber line for specialty/hollow fiber.
Q. Sustainability of margin expansion and whether double-digit EBITDA margin is achievable in FY28-FY29.
Targeting double-digit EBITDA margins structurally as domestic PTA capacity lowers input costs, Chinese export dumping subsides due to currency depreciation, and no major domestic polyester capacity is in the pipeline.
Q. Downstream integration plans into fabrics or weaving.
Management explicitly confirmed no plans to move down the value chain into weaving or fabrics.
Research and educational content only. Not investment advice.